Trade

with

Oncolytics Biotech Inc
(NASDAQ: ONCY)
AdChoices
0.4899
+0.0019
+0.39%
After Hours :
-
-
-

Open

0.5116

Previous Close

0.4880

Volume (Avg)

65.74k (371.48k)

Day's Range

0.4702-0.5137

52Wk Range

0.4000-2.89

Market Cap.

43.23M

Dividend Rate ( Yield )

-

Beta

1.86

Shares Outstanding

87.54M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 0

    • Net Income

    • -20.91M

    • Market Cap.

    • 43.23M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.86

    • Forward P/E

    • -2.08

    • Price/Sales

    • -

    • Price/Book Value

    • 2.97

    • Price/Cash flow

    • -1.87

      • EBITDA

      • -21.11M

      • Return on Capital %

      • -74.55

      • Return on Equity %

      • -88.05

      • Return on Assets %

      • -74.55

      • Book Value/Share

      • 0.15

      • Shares Outstanding

      • 87.54M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 3.79

        • Credit Rating

        • -

        • Analysts

        • 5

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -0.21

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 0.00

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -

            • 82.75

            • Pre-Tax Margin

            • -

            • 39.38

            • Net Profit Margin

            • -

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 5.34

              • 2.92

              • Quick Ratio

              • 5.17

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.22

              • 2.21

              • Book Value/Share

              • 0.17

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -1.93

                • 243.90

                • P/E Ratio 5-Year High

                • -30.21

                • 634.30

                • P/E Ratio 5-Year Low

                • -1.74

                • 124.82

                • Price/Sales Ratio

                • -

                • 9.29

                • Price/Book Value

                • 2.68

                • 8.39

                • Price/Cash Flow Ratio

                • -1.87

                • 49.75

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -88.05

                        (-101.30)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -74.55

                        (-81.30)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -88.05

                        (-101.30)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • -

                      • 1.48

                      • Asset Turnover

                      • -

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -21.23M
                      Operating Margin
                      -
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -1.87
                      Ownership

                      Institutional Ownership

                      8.80%

                      Top 10 Institutions

                      7.99%

                      Mutual Fund Ownership

                      2.84%

                      Float

                      98.61%

                      5% / Insider Ownership

                      -

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Selectra J. Lamarck Biotech

                      •  

                        1,119,300

                      • 0.00

                      • 1.27

                      • Scotia Canadian Small Cap Fund

                      •  

                        347,200

                      • 0.00

                      • 0.40

                      • Russell Smaller Companies Pool

                      •  

                        293,400

                      • 0.00

                      • 0.34

                      • Canadian Equity Fund

                      •  

                        187,710

                      • -48.77

                      • 0.21

                      • North Growth Canadian Equity

                      •  

                        147,000

                      • 0.00

                      • 0.17

                      • SEI Canadian Small Co Equity

                      •  

                        131,040

                      • -48.79

                      • 0.15

                      • iShares S&P/TSX Small Cap

                      •  

                        121,740

                      • 10.49

                      • 0.14

                      • AGF Canadian Growth Equity Class

                      •  

                        99,748

                      • -75.83

                      • 0.12

                      • Atomo Sicav Prisma

                      •  

                        15,000

                      • 0.00

                      • 0.02

                      • IG AGF Canadian Diversified Growth Fund

                      •  

                        12,675

                      • -70.37

                      • 0.01

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • 1832 Asset Management L.P

                      •  

                        2,826,250

                      • 0.00%

                      • 3.22

                      • Russell Frank Co

                      •  

                        1,237,100

                      • +22.98%

                      • 1.41

                      • SELECTRA MANAGEMENT COMPANY S.A.

                      •  

                        1,119,300

                      • 0.00%

                      • 1.27

                      • Bank of Nova Scotia

                      •  

                        500,000

                      • 0.00%

                      • 0.57

                      • Scotia Asset Management

                      •  

                        347,200

                      • 0.00%

                      • 0.40

                      • Morgan Stanley & Co Inc

                      •  

                        209,765

                      • -5.99%

                      • 0.24

                      • Canada Pension Plan Investment Board

                      •  

                        200,105

                      • 0.00%

                      • 0.23

                      • AGF Investments

                      •  

                        196,749

                      • -1.40%

                      • 0.22

                      • Arnhold & S. Bleichroeder Advisers, LLC

                      •  

                        188,600

                      • -55.85%

                      • 0.22

                      • VSR Financial Services, Inc.

                      •  

                        185,930

                      • +3.97%

                      • 0.21

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Slow Growth

                      Style

                      Small Value

                      Oncolytics Biotech, Inc., was incorporated on April 2, 1998 under the Business Corporations Act (Alberta) as 779738 Alberta Ltd. The Company is a development stage biopharmaceutical company that focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The Company focused on the development of oncolytic viruses for use as cancer therapeutics. Its product, REOLYSIN®, a proprietary formulation of the human reovirus, is in late stage (Phase III) clinical testing in head and neck cancers.

                      Key People

                      Dr. Bradley G. Thompson,PhD

                      CEO/Chairman of the Board/President/Director

                      Dr. Matthew C. Coffey,PhD

                      Co-Founder/COO/Director

                      Kirk J. Look

                      CFO

                      Mary Ann Dillahunty

                      Vice President, Divisional

                      Mr. Ed Levy,PhD

                      Director

                      • Oncolytics Biotech Inc

                      • 210, 1167 Kensington Crescent NW

                      • Calgary, AB T2N 1X7

                      • CAN.Map

                      • Phone: +1 403 670-7377

                      • Fax: +1 403 283-0858

                      • oncolyticsbiotech.com

                      Incorporated

                      1998

                      Employees

                      25

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: